JAMA Surg:乳腺癌根治术后都可行即刻乳房重建术?

2017-07-22 MedSci MedSci原创

通常建议乳腺癌改良根治术后行即刻乳房重建,因为普遍认为这可为患者带来心理社会效益,并可更好的恢复形体外貌。然而,即刻乳房重建的益处并没有考虑到严重并发症的可能。近日,据来自华盛顿大学的一项新的研究表明,考虑到一些患者的危险因素,如肥胖、糖尿病或吸烟,乳房切除术后延迟行乳房假体重建可能降低严重创伤并发症的发生风险,该研究结果已在线发表于JAMA Surgery。研究人员纳入了2004年1月到2011

通常建议乳腺癌改良根治术后行即刻乳房重建,因为普遍认为这可为患者带来心理社会效益,并可更好的恢复形体外貌。然而,即刻乳房重建的益处并没有考虑到严重并发症的可能。近日,据来自华盛顿大学的一项新的研究表明,考虑到一些患者的危险因素,如肥胖、糖尿病或吸烟,乳房切除术后延迟行乳房假体重建可能降低严重创伤并发症的发生风险,该研究结果已在线发表于JAMA Surgery。

研究人员纳入了2004年1月到2011年12月接受乳腺癌改良根治术的女性,年龄为18-64岁。从一个商业保险索赔数据库中提取数据,患者分布在12个州。研究人员比较了根治术后即刻(IR;术后7天内)、延迟(DR),以及二次(SR)使用假体或自体组织重建乳房术后手术部位感染发生率(SSI)和非感染性伤口并发症(NIWCs)。

结果,共17293名女性(平均年龄50岁)接受了乳腺癌切除术。研究人员发现,与延迟或二次植入重建相比,即刻修复患者的SSI和NIWCs发生率略高。即刻修复后发生了SSI或NIWCs的女性行SR后并发症发生的风险升高,且需要接受更多的乳房手术。

作者指出,本研究中使用的索赔数据是出于行政管理的目的,且具有局限性,包括诊断分类错误以及SSIs 和 NIWCs可能记录不全等。

最后研究人员表示,在考虑行IR时,应注重患者的心理社会和手术技术效益与术后并发症的风险之间的平衡。对于高风险患者,可能受益于延迟而非即刻植入重建,以减少乳房切除术后的并发症。

原始出处:

Some women may benefit from delaying breast reconstruction following mastectomy. MNT, Published Friday 21 July 2017.

Margaret A. Olsen, Katelin B. Nickel, et al., Comparison of Wound Complications After Immediate, Delayed, and Secondary Breast Reconstruction Procedures. JAMA Surg. Published online July 19, 2017. doi:10.1001/jamasurg.2017.2338.

本文为梅斯医生(MedSci)原创整理编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1399715, encodeId=cb341399e153d, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586060, encodeId=3d84158606099, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225538, encodeId=06fa2255388a, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 23 18:48:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225222, encodeId=8c2f2252221d, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 23 00:33:06 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1399715, encodeId=cb341399e153d, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586060, encodeId=3d84158606099, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225538, encodeId=06fa2255388a, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 23 18:48:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225222, encodeId=8c2f2252221d, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 23 00:33:06 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
    2017-07-24 jeanqiuqiu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1399715, encodeId=cb341399e153d, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586060, encodeId=3d84158606099, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225538, encodeId=06fa2255388a, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 23 18:48:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225222, encodeId=8c2f2252221d, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 23 00:33:06 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
    2017-07-23 虈亣靌

    不错的文章,值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1399715, encodeId=cb341399e153d, content=<a href='/topic/show?id=72406223398' target=_blank style='color:#2F92EE;'>#根治术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62233, encryptionId=72406223398, topicName=根治术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=03a52234941, createdName=bluefate122, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586060, encodeId=3d84158606099, content=<a href='/topic/show?id=38f8622191b' target=_blank style='color:#2F92EE;'>#根治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62219, encryptionId=38f8622191b, topicName=根治)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26d917348678, createdName=jeanqiuqiu, createdTime=Mon Jul 24 11:46:00 CST 2017, time=2017-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225538, encodeId=06fa2255388a, content=不错的文章,值得学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Sun Jul 23 18:48:36 CST 2017, time=2017-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=225222, encodeId=8c2f2252221d, content=学习了谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=550d2008262, createdName=luominglian113, createdTime=Sun Jul 23 00:33:06 CST 2017, time=2017-07-23, status=1, ipAttribution=)]
    2017-07-23 luominglian113

    学习了谢谢分享

    0

相关资讯

Indian J Anaesth:乳腺癌改良根治术中,SPB可作为PVB的替代镇痛技术

乳腺癌改良根治术(MRM)可能与严重的术后疼痛有关,导致慢性疼痛综合征的发生。本研究旨在对比两种超声引导下神经阻滞术后镇痛的效果:椎旁阻滞(PVB)和前锯肌平面阻滞(SPB)。采用双盲、随机对照研究设计,纳入了50名择期接受MRM腋下淋巴结清扫术的成年女性。静脉注射咪达唑仑1 mg、芬太尼1.5 mcg/kg、丙泊酚1–2 mg/kg、维库溴铵0.1 mg/kg诱导全身麻醉后,T4时给予患者超声引